Bio-Rad to acquire Curiosity Diagnostics for up to $170M

Bio-Rad Laboratories agreed to acquire all shares of Curiosity Diagnostics from Scope Fluidics for up to $170 million, including $100 million in cash and up to $70 million in milestone payments. Curiosity Diagnostics is developing a rapid PCR system for molecular diagnostics.

“We are excited to have the Curiosity Diagnostics team join Bio-Rad’s Clinical Diagnostics Group and to work closely together to bring a new generation of rapid PCR systems to market.”nasdaq.com

• 2 sources
• nasdaq.comBio-Rad Acquires Curiosity Diagnostics | NasdaqAug 3, 2022
• clairfield.comClairfield advises Scope Fluidics on the sale of its subsidiary Curiosity Diagnostics to Bio-Rad Laboratories for USD 170 million - ClairfieldIoanaAug 3, 2022

Summarized from public sources; check the original articles before acting on it.